Literature DB >> 15861133

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs.

Michelle S Longworth1, Regina Wilson, Laimonis A Laimins.   

Abstract

The E7 proteins of human papillomaviruses (HPVs) contribute to oncogenesis by associating with Rb family members as well class I histone deacetylases (HDACs). The binding of HDACs is also important for the maintenance of viral episomes during the differentiation-dependent productive life cycle. The effects of E7 and other viral proteins on E2F family members were examined in differentiating keratinocytes. E7 was found to specifically activate E2F2 transcription in suprabasal keratinocytes through its ability to bind HDACs. Chromatin immunoprecipitation assays demonstrated that, in differentiating cells, E7 acts to inhibit HDAC binding to the E2F2 promoter resulting in activation of expression. Reduction of E2F2 levels through the use of siRNA confirmed that E2F2 expression facilitated HPV replication but its loss did not affect cell proliferation. Our study demonstrates a mechanism by which binding of HDACs to E7 directly modulates viral replication and identifies E2F2 as a possible target for antiviral therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861133      PMCID: PMC1142589          DOI: 10.1038/sj.emboj.7600651

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  E2F family members are differentially regulated by reversible acetylation.

Authors:  G Marzio; C Wagener; M I Gutierrez; P Cartwright; K Helin; M Giacca
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis.

Authors:  R S Maser; O K Mirzoeva; J Wells; H Olivares; B R Williams; R A Zinkel; P J Farnham; J H Petrini
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.

Authors:  Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.

Authors:  J S Park; E J Kim; H J Kwon; E S Hwang; S E Namkoong; S J Um
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

6.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

Authors:  Bing Ren; Hieu Cam; Yasuhiko Takahashi; Thomas Volkert; Jolyon Terragni; Richard A Young; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

7.  The Rb-family protein p107 inhibits translation by a PDK1-dependent mechanism.

Authors:  Constantin Makris; Laure Voisin; Edith Giasson; Christopher Tudan; David R Kaplan; Sylvain Meloche
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

Review 8.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

9.  The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3.

Authors:  M G Guenther; O Barak; M A Lazar
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  54 in total

1.  Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.

Authors:  Tonia R Wooldridge; Laimonis A Laimins
Journal:  Virology       Date:  2008-01-31       Impact factor: 3.616

Review 2.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 3.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 4.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 5.  Manipulation of the innate immune response by human papillomaviruses.

Authors:  Shiyuan Hong; Laimonis A Laimins
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

Review 6.  Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.

Authors:  Nicholas A Wallace; Denise A Galloway
Journal:  Semin Cancer Biol       Date:  2014-01-08       Impact factor: 15.707

7.  Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.

Authors:  Zhenhua Lin; Martina Bazzaro; Mei-Cheng Wang; Kwun C Chan; Shiwen Peng; Richard B S Roden
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA.

Authors:  Scott S Terhune; Nathaniel J Moorman; Ileana M Cristea; John Paul Savaryn; Christian Cuevas-Bennett; Michael P Rout; Brian T Chait; Thomas Shenk
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

Review 9.  Human papillomaviruses and the interferon response.

Authors:  Melanie Beglin; Marta Melar-New; Laimonis Laimins
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.